DIPSS-plus improves outcome prediction after allogeneic haematopoietic stem cell transplantation (HSCT) for myelofibrosis

被引：0
|
作者：
Ditschkowski, M. [1 ]
Elmaagacli, A. H. [1 ]
Steckel, N. K. [1 ]
Gromke, T. [1 ]
Trenschel, R. [1 ]
Koldehoff, M. [1 ]
Beeen, D. W. [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [41] Transfusion requirements after allogeneic haematopoietic stem cell transplantation
    Bini-Antunes, M
    Santos, L
    Campilho, F
    Rosales, M
    Amado, F
    Campos, A
    Vaz, CP
    Pimentel, P
    Carvalhais, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S121 - S122
  • [42] Adverse effect of cytotoxic pre-treatment for myelofibrosis on survival after allogeneic haematopoietic stem cell transplantation
    Ditschkowski, M.
    Trenschel, R.
    Steckel, N. K.
    Elmaagacli, A. H.
    Schulte, C.
    Ottinger, H.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S309 - S309
  • [43] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Yok-Lam Kwong
    Annals of Hematology, 2016, 95 : 1191 - 1192
  • [44] Cerebral infections after allogeneic haematopoietic stem cell transplantation
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Keller, MT
    Schulte, C
    Hlinka, M
    Koldehoff, M
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2006, 37 : S168 - S168
  • [45] The outcome of allogeneic hematopoietic stem cell transplantation for patients with primary myelofibrosis
    Sun, K.
    Tsai, X. C. -H.
    Liu, J. -H.
    Hsu, S. -C.
    Chou, W. -C.
    Liao, X. -W.
    Hou, H. -A.
    Ko, B. -S.
    Tien, H. -F.
    Tang, J. -L.
    Yao, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 161 - 161
  • [46] Haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation
    Al Sabty, F.
    Demeckova, E.
    Bojtarova, E.
    Czako, B.
    Hrubisko, M.
    Kubalova, S.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S84 - S84
  • [47] Improved outcome after T-cell depleted allogeneic hematopoietic stem cell transplantation for myelofibrosis
    Simonetta, F.
    Casini, A.
    Wilk, M.
    Ecsedi, M.
    Andres, M.
    Gerull, S.
    Masouridi-Levrat, S.
    Beauverd, Y.
    Mohty, B.
    Bucher, C.
    Stern, M.
    Manz, M.
    Nair, G.
    Schanz, U.
    Passweg, J.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S292 - S292
  • [48] Erythropoietin in anaemias after allogeneic haematopoietic stem cell transplantation
    Stadler, M
    Reuter, C
    Varvenne, M
    Elser, C
    Kamal, H
    Eder, M
    Ganser, A
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S186 - S186
  • [49] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1191 - 1192
  • [50] Phenotype of TP53 and influence on outcome after allogeneic stem cell transplantation for myelofibrosis
    Gagelmann, N.
    Badbaran, A.
    Panagiota, V
    Thol, F.
    Heuser, M.
    Wolschke, C.
    Schroeder, T.
    Rautenberg, C.
    Reinhardt, H. C.
    Cassinat, B.
    Robin, M.
    Scott, B. L.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 80 - 80
12345